Nomura Asset Management CO LTD Regeneron Pharmaceuticals, Inc. Transaction History
Nomura Asset Management CO LTD
- $35.5 Billion
- Q2 2025
A detailed history of Nomura Asset Management CO LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 56,014 shares of REGN stock, worth $36.5 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
56,014
Previous 93,292
39.96%
Holding current value
$36.5 Million
Previous $59.2 Million
50.3%
% of portfolio
0.08%
Previous 0.19%
Shares
43 transactions
Others Institutions Holding REGN
# of Institutions
1,437Shares Held
88.9MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$6.14 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.51 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.69 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.15 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.49 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $69.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...